Stocktoria

ANGIODYNAMICS INC ANGO

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2004-05-27 · LEI

ANGIODYNAMICS INC financials (annual)

Revenue
$349.6M $261.7M $270.6M $264.2M $291.0M $316.2M $338.8M $303.9M $292.5M $320.2M 2017201820192020202120222023202420252026
Net income
$5.0M $16.3M $61.3M -$166.8M -$31.5M -$26.5M -$52.4M -$184.3M -$34.0M -$36.7M 2017201820192020202120222023202420252026
Free cash flow
$52.7M $38.9M $34.3M -$21.8M $18.9M -$11.5M -$3.7M -$30.7M -$14.6M $508000 2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$320.2M$292.5M$303.9M$338.8M$316.2M$291.0M$264.2M$270.6M$261.7M$349.6M
Gross profit$174.9M$157.7M$154.7M$174.2M$165.7M$156.8M$150.3M$156.0M$143.9M$143.9M
R&D expense$29.4M$26.2M$31.5M$29.9M$30.7M$36.4M$29.7M$28.3M$24.3M$24.1M
Operating income-$39.9M-$40.0M-$192.4M-$51.2M-$28.5M-$35.3M-$167.1M-$9.4M-$14.2M-$11.2M
Interest expense-$1.6M$2.7M$688,000$861,000$907,000$5.1M$3.1M$2.8M
Income tax$442,000-$39,000-$7.3M-$2.0M-$3.4M-$4.5M-$1.3M-$3.6M-$11.0M-$7.2M
Net income-$36.7M-$34.0M-$184.3M-$52.4M-$26.5M-$31.5M-$166.8M$61.3M$16.3M$5.0M
EPS (diluted)$-0.88$-0.83$-4.59$-1.33$-0.68$-0.82$-4.39$1.64$0.44$0.14
Operating cash flow$3.1M-$10.1M-$28.2M$78,000-$7.2M$24.1M-$14.6M$37.4M$41.3M$55.7M
Free cash flow$508,000-$14.6M-$30.7M-$3.7M-$11.5M$18.9M-$21.8M$34.3M$38.9M$52.7M
Cash & equivalents$53.9M$55.9M$76.1M$44.6M$28.8M$48.2M$54.4M$227.6M$74.1M$47.5M
Inventory$52.4M$62.0M$60.6M$55.3M$51.4M$48.6M$59.9M$40.1M$39.3M$54.5M
Total assets$267.2M$280.1M$317.7M$532.6M$552.8M$561.4M$594.2M$836.4M$705.5M$708.0M
Total liabilities$96.3M$97.2M$112.1M$154.3M$128.3M$122.0M$139.3M$221.6M$162.9M$192.9M
Shareholders' equity$170.8M$183.0M$205.6M$378.3M$424.5M$439.5M$454.9M$614.8M$542.6M$515.0M

Growth · year-over-year · Revenue CAGR -1%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth+9.5%-3.8%-10.3%+7.1%+8.7%+10.2%-2.4%+3.4%-25.2%-1.2%
Net income growth-371.9%+275.5%+226.2%
EPS growth-367.7%+272.7%+214.3%
Free cash flow growth-160.8%-163.5%-11.8%-26.3%+23.0%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.